See more : Gaush Meditech Ltd (2407.HK) Income Statement Analysis – Financial Results
Complete financial analysis of SeaStar Medical Holding Corporation (ICU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SeaStar Medical Holding Corporation, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Beyond Lithium Inc. (BYDMF) Income Statement Analysis – Financial Results
- APAC Resources Limited (1104.HK) Income Statement Analysis – Financial Results
- Generations Bancorp NY, Inc. (GBNY) Income Statement Analysis – Financial Results
- Cabral Gold Inc. (CBR.V) Income Statement Analysis – Financial Results
- Phoenix Copper Limited (PXCLY) Income Statement Analysis – Financial Results
SeaStar Medical Holding Corporation (ICU)
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 5.97M | 2.82M | 2.77M | 4.03M |
| General & Administrative | 8.01M | 6.60M | 1.68M | 2.43M |
| Selling & Marketing | 32.00K | 0.00 | 0.00 | 0.00 |
| SG&A | 8.04M | 6.60M | 1.68M | 2.43M |
| Other Expenses | 200.00K | 0.00 | 91.00K | 84.00K |
| Operating Expenses | 14.21M | 11.61M | 4.45M | 6.45M |
| Cost & Expenses | 14.21M | 11.61M | 4.45M | 6.45M |
| Interest Income | 0.00 | 630.00 | 212.00 | 3.31K |
| Interest Expense | 1.08M | 630.00K | 212.00K | 3.31M |
| Depreciation & Amortization | 14.01M | 11.61M | 4.45M | 6.45M |
| EBITDA | -11.14M | -11.61M | 0.00 | 0.00 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -14.21M | -11.61M | -4.45M | -6.45M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -12.02M | -11.40M | -148.00K | 3.19M |
| Income Before Tax | -26.23M | -23.01M | -4.60M | -3.27M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 1.00K | -1.00K | 9.00K |
| Net Income | -26.23M | -23.01M | -4.60M | -3.28M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -30.29 | -70.16 | -15.90 | -27.15 |
| EPS Diluted | -30.26 | -70.07 | -15.87 | -27.15 |
| Weighted Avg Shares Out | 866.00K | 328.00K | 289.00K | 120.67K |
| Weighted Avg Shares Out (Dil) | 866.81K | 328.45K | 289.55K | 120.67K |
FINAL ICU DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Seastar Medical Holding Corp. Investors to Join the Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / September 6, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Seastar Medical Holding Corp. ("Seastar" or "the Company") (NASDAQ:ICU;...
Shareholders that lost money on SeaStar Medical Holding Corporation(ICU) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK , Sept. 6, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in SeaStar Medical Holding Corporation ("SeaStar Medical" or the "Company") (NASDAQ: ICU) of a class action securities lawsuit.
Class Action Filed Against SeaStar Medical Holding Corporation (ICU) - September 6, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / September 6, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
SeaStar Medical Holding Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ICU
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
ICU LAWSUIT ALERT: Levi & Korsinsky Notifies SeaStar Medical Holding Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
Shareholders that lost money on SeaStar Medical Holding Corporation (ICU) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in SeaStar Medical Holding Corporation ("SeaStar Medical" or the "Company") (NASDAQ: ICU) of a class action securities lawsuit.
SeaStar Medical Holding Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 6, 2024 to Discuss Your Rights - ICU
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
SeaStar Medical Holding Corporation Is Being Sued For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SeaStar Medical Holding Corporation ("SeaStar" or "the Company") (NASDAQ:ICU) for violations of...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in SeaStar Medical Holding Corporation of Class Action Lawsuit and Upcoming Deadlines - ICU
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against SeaStar Medical Holding Corporation ("SeaStar" or the "Company") (NASDAQ:ICU) and certain officers. The class action, filed in the...
September 6, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ICU
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
Source: https://incomestatements.info
Category: Stock Reports